Showing results (651-660 of 16,804) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|June 17, 2025
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studiesMichael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.British Journal of Haematology|June 17, 2025
Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohortUmut Yılmaz, Esra Terzi Demirsoy, Fatma Keklik Karadağ, et al.British Journal of Haematology|June 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive modelMoshe Mittelman, Ariel Israel, Howard S Oster, et al.British Journal of Haematology|May 26, 2025
Real-world assessment of acute red cell exchange for stroke in sickle cell diseaseSamuel R Wilson, Denis Noubouossie, Jane A Little, et al.British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.British Journal of Haematology|June 4, 2025
Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysisLuxin Yang, Xiaoyu Lai, Lizhen Liu, et al.British Journal of Haematology|May 25, 2025
Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusionRyo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa, et al.British Journal of Haematology|May 23, 2025
RETRACTION: IPO-trimethylation of Histone H3-lysine9 Associated with P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid LeukaemiaBritish Journal of Haematology|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology GuidelineSridhar Chaganti, Christopher P Fox, Bernard D Maybury, et al.Pageof 1,681